Los Gatos, California – Venova Medical, a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access, today announced the successful completion of patient enrollment for the...
Los Gatos, California – Venova Medical, a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access, announced today the enrollment of the first participants in the company’s...
(Los Gatos, California) – Venova Medical, Inc. (Venova Medical), a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access today announced that it will present an oral...
Robert Shahverdyan, MD, from Hamburg, Germany presented one-year results from the VENOS-1 first-in-human study, which examined the VelocityTM Percutaneous Arteriovenous Fistula (pAVF) System during the recent Controversies in Dialysis Access (CiDA) meeting held in...
Funding Will Support Clinical Studies of the VelocityTM pAVF System in Patients with Chronic Kidney and End-Stage Renal Disease (Los Gatos, California) – Venova Medical, Inc. (Venova Medical), a privately held company developing a next generation technology for...
Venova Medical has developed the VelocityTM pAVF System, a next generation percutaneous AVF technology designed to reduce the need for reinterventions to achieve fistula maturation, maintain functionality and improve vascular access outcomes while reducing costs....
Venova Medical will be attending the 2024 Charing Cross Symposium (CX) being held April 23-25,2024 in London, England. The meeting will feature a presentation by Robert Shahverdyan, MD, Head of Vascular Access Center at the Asklepios Klinik Barmbek in Hamburg,...
Venova Medical will be attending the 20th Annual Scientific Meeting of the American Society of Diagnostic and Interventional Nephrology (ASDIN) being held from February 23rd to 25th in New Orleans, Louisiana. Additionally, Robert Shahverdyan, MD, Head of Vascular...
While currently available percutaneous arteriovenous fistula (pAVF) devices have demonstrated a high rate of technical procedural success, secondary interventions are often required to achieve fistula maturation with these devices. CLICK HERE to read an excellent...
During the recent Charing Cross (CX) International Symposium held in London, Robert Shahverdyan, MD detailed the challenges associated with the use of current endovascular arteriovenous fistula (endoAVF) devices and provided insights from his clinical experience with...
